Search hospitals > Ohio > Cincinnati
Good Samaritan Hospital - Cincinnati
Claim this profileCincinnati, Ohio 45220
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Ovarian Cancer
Conducts research for Cancer
326 reported clinical trials
7 medical researchers
Summary
Good Samaritan Hospital - Cincinnati is a medical facility located in Cincinnati, Ohio. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Ovarian Cancer, Cancer and other specialties. Good Samaritan Hospital - Cincinnati is involved with conducting 326 clinical trials across 528 conditions. There are 7 research doctors associated with this hospital, such as Richard L. Deming, Shahzad Siddique, Patrick Muck, MD, and Mehmet S. Copur.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
2Lung Cancer
Global LeaderStage IV
Stage II
Stage I
Top PIs
Richard L. DemingMercy Medical Center - Des Moines6 years of reported clinical research
Expert in Breast Cancer
Expert in Cancer
178 reported clinical trials
242 drugs studied
Shahzad SiddiquePenrose-Saint Francis Healthcare2 years of reported clinical research
Expert in Breast Cancer
Expert in Cancer
124 reported clinical trials
187 drugs studied
Patrick Muck, MDGood Samaritan Hospital of Cincinnati4 years of reported clinical research
Studies Varicose veins
Studies Carotid Artery Disease
7 reported clinical trials
7 drugs studied
Mehmet S. CopurBethesda North Hospital13 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
3 reported clinical trials
14 drugs studied
Clinical Trials running at Good Samaritan Hospital - Cincinnati
Lung Cancer
Bladder Cancer
Breast Cancer
Ovarian Cancer
Breast cancer
Esophageal cancer
Prostate Cancer
Pancreatic Cancer
Cancer
Uterine Cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Treatment Timing
for Non-Small Cell Lung Cancer
This phase III trial compares standard therapy given after surgery (adjuvant) to standard therapy given before and after surgery (perioperative) in treating patients with stage II-IIIB non-small cell lung cancer (NSCLC) that can be removed by surgery (resectable). The usual approach for patients with resectable NSCLC is chemotherapy and/or immunotherapy before surgery, after surgery, or both before and after surgery. This study is being done to find out which approach is better at treating patients with lung cancer. Treatment will be administered according to the current standard of care at the time of enrollment. Chemotherapy options may include cisplatin, carboplatin, pemetrexed, gemcitabine, docetaxel, and vinorelbine at standard doses according to the treating physician. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of tumor cells. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Pemetrexed is in a class of medications called antifolate antineoplastic agents. It works by stopping cells from using folic acid to make deoxyribonucleic acid (DNA) and may kill tumor cells. Gemcitabine is a chemotherapy drug that blocks the cells from making DNA and may kill tumor cells. Docetaxel is in a class of medications called taxanes. It stops tumor cells from growing and dividing and may kill them. Other chemotherapy drugs, such as vinorelbine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading . Immunotherapy with monoclonal antibodies, such as nivolumab, pembrolizumab, and atezolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Starting treatment with chemotherapy and immunotherapy prior to surgery and continuing treatment after surgery may be a more effective treatment option than adjuvant therapy alone in patients with stage II-IIIB resectable NSCLC.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Good Samaritan Hospital - Cincinnati?
Good Samaritan Hospital - Cincinnati is a medical facility located in Cincinnati, Ohio. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Ovarian Cancer, Cancer and other specialties. Good Samaritan Hospital - Cincinnati is involved with conducting 326 clinical trials across 528 conditions. There are 7 research doctors associated with this hospital, such as Richard L. Deming, Shahzad Siddique, Patrick Muck, MD, and Mehmet S. Copur.
Where is Good Samaritan Hospital - Cincinnati located?
**Good Samaritan Hospital - Cincinnati, Ohio**
- **Address:** 375 Dixmyth Ave, Cincinnati, Ohio
- **Parking Information:**
- Non-emergency patients and visitors: Garage accessible from Dixmyth Avenue.
- Emergency department and breast center visitors: Garage accessible from Clifton Avenue.
Who should I call to ask about financial aid or insurance network?
**Good Samaritan Hospital Financial Assistance Contact Information:**
- **Mail:** Financial Assistance, TriHealth, Inc., PO Box 639461, Cincinnati, Ohio 45263-9461
- **Email:** THHCAPFinAsst@TriHealth.com
- **Fax:** (513) 853-4742
**Insurance Inquiries:**
- **Phone:** (866) 904-6871
What insurance does Good Samaritan Hospital - Cincinnati accept?
Good Samaritan Hospital - Cincinnati, part of TriHealth, accepts most major insurance plans. It is recommended to confirm your plan's coverage with your insurance provider.
What awards or recognition has Good Samaritan Hospital - Cincinnati received?
Good Samaritan Hospital, located in Cincinnati, Ohio, is celebrated for its exceptional healthcare services. It has been ranked as the fourth-best hospital in the Cincinnati area by U.S. News & World Report for 2023-24. Furthermore, it boasts the Comprehensive Stroke Center designation from The Joint Commission, distinguishing it within the top 3.5% of U.S. hospitals for stroke care.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.